Skip to main content

Table 1 Patient and tumor characteristics

From: Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

Clinicopathologic features n = 25 (%)
Median age (years) 75
Age range 42–81
Sex
 Male 18 (72)
 Female 7 (28)
Tumor location
 Pancreas head 20 (80)
 Pancreas body & tail 5 (20)
T stage
 T1 – T2 7 (28)
 T3 18 (72)
N status
 N0 12 (48)
 N1–2 13 (52)
R status
 R0 19 (76)
 R1 5 (20)
 Rx 1 (4)
Lymphovascular invasion
 L0 15 (60)
 L1 10 (40)
Perineural invasion
 Pn0 2 (8)
 Pn1 23 (92)
Grading
 G2 13 (52)
 G3 12 (48)
Adjuvant chemotherapy
 Yes 17 (68)
 No 8 (32)
Time to relapse (months)
 Median 10
 Range 0.5–42
Overall survival (months)
 Median 22
 Range 0.5–46